Guru P. Sonpavde, MD
Guru P. Sonpavde, MD, serves as Phase I and Genitourinary Oncology Director at AdventHealth Cancer Institute and is a professor at the University of Central Florida. He specializes in advanced bladder and urothelial carcinoma therapies, actively contributing to clinical research and oncology discourse. Dr. Sonpavde is affiliated with leading oncology organizations including ASCO, ESMO, and AACR, underscoring his expertise in cancer therapeutics and translational medicine.
Guru P. Sonpavde, MD
Guru P. Sonpavde, MD, serves as Phase I and Genitourinary Oncology Director at AdventHealth Cancer Institute and is a professor at the University of Central Florida. He specializes in advanced bladder and urothelial carcinoma therapies, actively contributing to clinical research and oncology discourse. Dr. Sonpavde is affiliated with leading oncology organizations including ASCO, ESMO, and AACR, underscoring his expertise in cancer therapeutics and translational medicine.